Author

Martin Beer

Institution: Friedrich-Loeffler-Institut

Observed institution: Friedrich-Loeffler-Institut

ORCID: 0000-0002-0598-5254

Observed ORCID: 0000-0002-0598-5254

OpenAlex ID: A5151908950

Oropouche virus: transmission, epidemiology, genetic diversity, and public health implications

2026 · Lorenzo Subissi, James R. Otieno, et al. · EClinicalMedicine · 3

Adapted Live SARS‐CoV‐2 Vaccine Elicits Rapid Mucosal Immunity, Protects From Disease, and Reduces Shedding of XBB.1.5

2026 · Jana Kochmann, Tobias Britzke, et al. · European Journal of Immunology · 1

A multimodal in situ framework for spatial characterization applied on SARS-CoV-2 live-attenuated vaccines in the nasal mucosa

2026 · Tobias Britzke, Jacob Schön, et al. · iScience

Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV

2026 · Enja Tatjana Kipfer, Jacob Schön, et al. · iScience

Adaptation and validation of an influenza a subtyping panel for detection of H1pdm09, H3 and H5 on a high-throughput RT-qPCR system

2026 · Katja Giersch, Dominik Nörz, et al. · Scientific Reports

One and Done: A safe, adaptable single-cycle SARS-CoV-2 vaccine platform blocks XBB.1.5 infection and transmission

2026 · Jacob Schön, Nico Joel Halwe, et al. · bioRxiv (Cold Spring Harbor Laboratory)

Works count: 6

Citation count: 4

H-index: 1

I10-index: